Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cabaletta Bio, Inc. - Common Stock
(NQ:
CABA
)
2.390
-0.020 (-0.83%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cabaletta Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Know
↗
November 15, 2023
Via
Benzinga
Where Cabaletta Bio Stands With Analysts
↗
November 10, 2023
Via
Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 11/9
November 09, 2023
Via
Investor Brand Network
Cabaletta Bio: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle Platform
November 06, 2023
From
Cellares
Via
Business Wire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/24
October 24, 2023
Via
Investor Brand Network
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis
November 06, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November
October 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
7 Analysts Have This to Say About Cabaletta Bio
↗
October 24, 2023
Via
Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 10/23
October 23, 2023
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
↗
October 19, 2023
Via
Benzinga
The Latest Analyst Ratings for Cabaletta Bio
↗
October 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
↗
October 24, 2023
Via
Benzinga
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
October 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 9/12
September 12, 2023
Via
Investor Brand Network
Analyst Ratings for Cabaletta Bio
↗
September 05, 2023
Via
Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/23
August 23, 2023
Via
Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/18
August 18, 2023
Via
Investor Brand Network
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
September 19, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
September 18, 2023
Gainers
Via
Benzinga
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
↗
September 05, 2023
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
HC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
↗
August 11, 2023
Via
Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
September 05, 2023
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...
Via
Benzinga
The 7 Most Promising Momentum Stocks to Own Now
↗
August 31, 2023
These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
↗
September 05, 2023
Via
Benzinga
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
August 30, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
August 22, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
July 24, 2023
From
Cabaletta Bio
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.